AUTOLOGOUS CONDITIONED PLASMA
Genitourinary Syndrome of Menopause
University of Miamiother_biologicalPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Genitourinary Syndrome of Menopause cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Prasterone University Hospital, Ghent | Phase 4 | BB |
Estriol ITF Research Pharma, S.L.U. | Phase 2 | BB |
PILOCARPINUM Alliance for Clinical Trials in Oncology | Phase 3 | BB |
Dhea Hadassah Medical Organization | Phase 2/3 | B |
Polycarbophil University of Arkansas | Phase 2 | CCC |
Prasterone University of Arkansas | Phase 2 | CCC |
TESTOSTERONE UNDECYLATE Creighton University | Early Phase 1 | CC |
Promestriene Federal University of São Paulo | N/A | D |
Same molecule, other indications
AUTOLOGOUS CONDITIONED PLASMA is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →